Natera (NASDAQ:NTRA – Get Rating) issued its earnings results on Tuesday. The medical research company reported ($1.23) EPS for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. The company had revenue of $241.76 million for the quarter, compared to analysts’ expectations of $227.43 million. Natera had a negative return on equity […]